Lotemax Ophthalmic Suspension 0.5%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lotemax Ophthalmic Suspension 0.5%, covering 2019-11-19 to 2019-11-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Lotemax Ophthalmic Suspension 0.5% [Phase 4]